JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3676
Horizon Bancorp
HBNC
$988M
| $513K | ﹤0.01% |
47,954
-29,310
| -38% | -$299K |
2017 Q4
10 quarters
|
|
3677
UNIFI
UFI
$119M
| $513K | ﹤0.01% |
39,880
+27,929
| +234% | +$331K |
2013 Q2
28 quarters
|
|
|
PNNT
3678
Pennant Park Investment Corp
PNNT
$211M
| $512K | ﹤0.01% |
145,919
-108,949
| -43% | -$352K |
2013 Q2
28 quarters
|
|
3679
First Trust Rising Dividend Achievers ETF
RDVY
$25.3B
| $512K | ﹤0.01% |
16,595
-1,492
| -8% | -$43.4K |
2017 Q3
11 quarters
|
|
3680
CareDx
CDNA
$3.61B
| $510K | ﹤0.01% |
14,402
+842
| +6% | +$24K |
2017 Q4
10 quarters
|
|
3681
Cohen & Steers Duration Preferred & Income Fund
LDP
$552M
| $510K | ﹤0.01% |
22,637
+343
| +2% | +$7.67K |
2017 Q2
12 quarters
|
|
3682
Daktronics
DAKT
$856M
| $509K | ﹤0.01% |
116,969
-59,711
| -34% | -$264K |
2016 Q3
15 quarters
|
|
3683
iShares US Pharmaceuticals ETF
IHE
$1.6B
| $508K | ﹤0.01% |
9,897
-420
| -4% | -$21.1K |
2014 Q1
25 quarters
|
|
|
CNBKA
3684
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $507K | ﹤0.01% |
6,525
-8,557
| -57% | -$597K |
2013 Q2
28 quarters
|
|
|
CHMI
3685
Cherry Hill Mortgage Investment Corp
CHMI
$96.1M
| $505K | ﹤0.01% |
55,837
-80,482
| -59% | -$618K |
2016 Q2
16 quarters
|
|
3686
iShares MSCI Poland ETF
EPOL
$818M
| $505K | ﹤0.01% |
30,393
+4,040
| +15% | +$62.8K |
2015 Q4
18 quarters
|
|
3687
Team
TISI
$130M
| $503K | ﹤0.01% |
9,018
+7,334
| +436% | +$405K |
2013 Q2
28 quarters
|
|
3688
Opko Health
OPK
$1.17B
| $502K | ﹤0.01% |
147,317
+20,665
| +16% | +$46.3K |
2015 Q3
19 quarters
|
|
|
SHYF
3689
DELISTED
The Shyft Group
SHYF
| $502K | ﹤0.01% |
29,829
-18,227
| -38% | -$275K |
2016 Q4
14 quarters
|
|
|
GPOR
3690
DELISTED
Gulfport Energy Corp.
GPOR
| $501K | ﹤0.01% |
459,709
-423,158
| -48% | -$631K |
2013 Q2
28 quarters
|
|
3691
Hyatt Hotels
H
$14.8B
| $500K | ﹤0.01% |
9,929
+133
| +1% | +$7.08K |
2013 Q2
28 quarters
|
|
|
SPPI
3692
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $496K | ﹤0.01% |
146,727
-100
| -0.1% | -$291 |
2016 Q4
14 quarters
|
|
3693
Fidelity High Dividend ETF
FDVV
$10.2B
| $492K | ﹤0.01% |
18,175
+3,775
| +26% | +$97.8K |
2019 Q4
2 quarters
|
|
3694
CALL
Weyerhaeuser
WY
$13.3B
| $490K | ﹤0.01% |
+21,800
| New | +$441K |
2020 Q2
0 quarters
|
|
3695
Clearwater Paper
CLW
$325M
| $489K | ﹤0.01% |
13,535
-5,508
| -29% | -$153K |
2015 Q4
18 quarters
|
|
|
PPLT
3696
abrdn Physical Platinum Shares ETF
PPLT
$2.08B
| $488K | ﹤0.01% |
62,470
+360
| +0.6% | +$2.69K |
2015 Q4
18 quarters
|
|
3697
Bank of Marin Bancorp
BMRC
$444M
| $486K | ﹤0.01% |
14,568
-16,512
| -53% | -$523K |
2014 Q1
25 quarters
|
|
|
NWLI
3698
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $486K | ﹤0.01% |
2,387
-1,577
| -40% | -$301K |
2016 Q4
14 quarters
|
|
|
STSA
3699
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $486K | ﹤0.01% |
16,890
+1,003
| +6% | +$23.2K |
2019 Q4
2 quarters
|
|
|
VBIV
3700
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $485K | ﹤0.01% |
5,214
+3,579
| +219% | +$197K |
2019 Q2
4 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.